Sisi Urges Gov't to Continue National Projects, Roads Construction

President Abdel Fattah El Sisi met Saturday with Prime Minister Mostafa Madbouly, Minister of Transport Kamel al-Wazir in the presence of Major General Amir Sayed Ahmed, Advisor to the President for Urban Planning, and Major General Magdy Anwar, Chairman of the Board of Directors of the National Road Company.

"The meeting touched on the executive situation of the current national projects of the Ministry of Transport, especially those related to the road network and axes, as well as mass transit projects for connecting the new administrative capital to the cities and neighborhoods of Greater Cairo, and projects of subway lines,” according to Presidential Spokesperson Bassam Rady.

Rady noted that President Sisi urged the government to continue with the efforts of constructing roads and pivots projects throughout the country, as well as the comprehensive modernization of the transportation system and the enhancement of the capabilities of this pivotal sector in a qualitative way.

The Spokesman added that Wazir reviewed the executive position of the projects of constructing a number of major axes along the course of the Nile, as well as the new road and bridges network in the various governorates according to the specified timetables.

“The meeting also discussed the developments of the project to raise the efficiency of the circular road surrounding the Greater Cairo in its various phases and sectors, including projects to develop roads and axes in the south of the valley and Upper Egypt,” Rady stated.

In another regard, President Sisi requested concerned officials to manufacture a sufficient quantity of a Japanese drug through one of the pharmaceutical factories in the city of Tenth of Ramadan (north of Cairo), according to the Higher Education Minister  who noted that “We are working now to get the official approval from the Japanese side.”

Japan has started promoting the drug “Avigan” which has been approved in China for treating influenza, but has not been approved in the United States for that purpose, or for fighting any other disease.